2015/0309(CNS)

Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures

Basic information

2015/0309(CNS)

CNS - Consultation procedure

Decision

Subject

4.20.03 Drug addiction, alcoholism, smoking
7.30.30.04 Action to combat drugs and drug-trafficking

Status

Procedure completed

Key players

Key events

Date Event Reference Summary
18/12/2015 Initial legislative proposal published COM(2015)0674
21/12/2015 Legislative proposal published 15386/2015
11/04/2016 Committee referral announced in Parliament
28/04/2016 Vote in committee
10/05/2016 Committee report tabled for plenary, 1st reading/single reading A8-0175/2016
08/06/2016 Decision by Parliament T8-0258/2016
08/06/2016 Results of vote in Parliament
27/06/2016 Act adopted by Council after consultation of Parliament
27/06/2016 End of procedure in Parliament
02/07/2016 Final act published in Official Journal

Technical information

Procedure Information
Procedure reference 2015/0309(CNS)
Procedure type CNS - Consultation procedure
Nature of procedure Legislation
Legislative instrument Decision
Other legal basis Rules of Procedure EP 165
Stage reached in procedure Procedure completed
Committee dossier LIBE/8/05453

Documentation gateway

  • Document type Committee Reference Date Summary
    Committee draft report PE578.806 16/03/2016
    Committee report tabled for plenary, 1st reading/single reading A8-0175/2016 10/05/2016
    Text adopted by Parliament, 1st reading/single reading T8-0258/2016 08/06/2016
  • Document type Reference Date Summary
    Legislative proposal 15386/2015 21/12/2015
  • Document type Reference Date Summary
    Initial legislative proposal COM(2015)0674 18/12/2015